The consistency and value of immunotherapy

This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Immunotherapy offers survival extension for brain tumour patients and The evolution of assays for immuno-oncology research.

The first article looks into why data from a Phase III clinical trial offers promise for patients with a deadly form of brain cancer. 

The second article shares insight from Dr Shailendra Singh, Founder and CEO of Cellomatics Biosciences.